dual therapy
Sponsors
University Hospital, Tours, LMU Klinikum, University of British Columbia, Makassed General Hospital, Fundacion SEIMC-GESIDA
Conditions
Acute Coronary SyndromeAtrial FibrillationCoronary Artery DiseaseDigestive System
Helicobacter pylori gastritis
PaediatricsHIVHIV InfectionHIV InfectionsObstructive Sleep Apnea
Phase 3
Phase 4
APixaban vs. PhenpRocoumon in Patients With ACS and AF: APPROACH-ACS-AF
CompletedNCT02789917
Start: 2016-06-30End: 2020-08-31Updated: 2020-08-14
A Phase IV Study to Assess the Impact of the Change of Antiretroviral Treatment From Dual Therapy to Triple Therapy on Inflammation in Patients With HIV Infection
CompletedNCT04076423
Start: 2019-10-10End: 2024-01-16Updated: 2024-10-01
Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Emtricitabine in Virologically Suppressed HIV-1-positive Individuals in Mexico
RecruitingNCT06907056
Start: 2023-11-09End: 2026-11-30Target: 138Updated: 2025-04-04
Efficacy, Safety, and ToLerability of Switching to A Two-Drug Regimen With DTG/3TC Compared to Maintaining A Three-Drug REgimen With BIC/FTC/TAF or DTG/3TC/ABC in ViroLogically SupprEssed PeopLe Living With HIV After 24 and 48 Weeks of Follow-Up
RecruitingNCT07138144
Start: 2025-07-12End: 2026-07-30Target: 156Updated: 2025-08-22
Unknown Phase
Dual Obstructive Sleep Apnea Therapy
NCT03435731
Start: 2018-03-08End: 2018-12-31Target: 30Updated: 2018-05-02
Metoclopramide-Ondansetron vs. Metoclopramide Therapy for Treatment of Nausea and Vomiting Post Laparoscopic Surgery
CompletedNCT03459248
Start: 2018-02-15End: 2019-07-31Updated: 2019-09-27
Helicobacter pylori eradication in children
Active, not recruitingPACTR201807134057681
Start: 2018-08-01Target: 156Updated: 2026-01-27
Duration of Dual Antiretroviral Therapy in Virologically Suppressed People Living With HIV and Factors Associated With Switching to Tritherapy : a Real-life Cohort
CompletedNCT06107140
Start: 2011-01-01End: 2023-05-01Updated: 2023-11-01